A detailed history of Luts & Greenleigh Group, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Luts & Greenleigh Group, Inc holds 6,184 shares of JNJ stock, worth $900,946. This represents 1.22% of its overall portfolio holdings.

Number of Shares
6,184
Previous 6,182 0.03%
Holding current value
$900,946
Previous $963 Million 0.67%
% of portfolio
1.22%
Previous 1.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $291 - $317
2 Added 0.03%
6,184 $969 Million
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $7,008 - $7,851
-45 Reduced 0.72%
6,182 $963 Million
Q2 2023

Jul 17, 2023

BUY
$154.35 - $166.11 $163,611 - $176,076
1,060 Added 20.51%
6,227 $1.03 Billion
Q1 2023

Apr 13, 2023

SELL
$151.05 - $180.26 $4,984 - $5,948
-33 Reduced 0.63%
5,167 $801 Million
Q4 2022

Mar 30, 2023

BUY
$160.2 - $179.79 $833,039 - $934,908
5,200 New
5,200 $918 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Luts & Greenleigh Group, Inc Portfolio

Follow Luts & Greenleigh Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luts & Greenleigh Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Luts & Greenleigh Group, Inc with notifications on news.